Skip to main content
. 2022 May 6;20:eAO6599. doi: 10.31744/einstein_journal/2022AO6599

Table 1. Characterization of the groups studied.

Variables* Group 1 Group 2
Total (n=65) Unfavorable intermediate and high risk (n=38) Total (n=91) Unfavorable intermediate and high risk (n=51)
Age, years 66.0 (59.0-71.0) 67.0 (61.0-71.5) 65.0 (58.7-69.2) 66.0 (60.7-71.2)
BMI, kg/m2 27.0 (26.0-30.7) 27.0 (26.0-30.2) 27.0 (25.5-30.0) 27.0 (25.0-30.0)
PSA, ng/dL 6.0 (4.5-10.0) 6.1 (5.1-10.8) 5.5 (3.6-8.2) 5.9 (4.8-10.3)

Results expressed as median and 95% confidence interval.

BMI: body mass index; PSA: prostatic specific antigen.